Form 4: Ani Pharmaceuticals Executive Reports Stock Transaction
Insider Transaction (Form 4)
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of Ani Pharmaceuticals Inc, reported a transaction in 2,466 shares of common stock on July 18, 2026.
Summary
- Tax/exercise-price withholding: disposed of 2,466 Common Stock at $79.20 ($195,307) on July 18, 2026; holds 74,924 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Meredith Cook — Officer (SR. VP, GENERAL COUNSEL & SEC.)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-18 | Tax/exercise-price withholding | Common Stock | 2,466 | $79 | $195.3K | 74,924 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-18 | Tax/exercise-price withholding (2,466 shares) |
Keywords
insider transaction, Form 4, ANIP, ANI PHARMACEUTICALS INC, neutral, Meredith Cook
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.